The suggestion is "followed by label extension in the larger adult population".
We don't know how that label extension would be approved, but it is a shorter pathway than another full BLA for adult GVHD, hence potential saving and quicker time to market. But, it does not mean no additional study or trial for adult GVHD.
The suggestion is "followed by label extension in the larger...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.043(3.90%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.14 | $1.08 | $5.748M | 5.172M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 31172 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 117104 | 27 |
View Market Depth
| Last trade - 15.18pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
0.043 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.14 | $1.08 | 1158657 | ||
| Last updated 15.35pm 18/06/2024 ? | |||||
| MSB (ASX) Chart |